Compugen (CGEN) Share-based Compensation (2018 - 2021)
Compugen (CGEN) reported Share-based Compensation of $11.9 million for Q4 2021, up 6.14% on a YoY basis from $11.2 million in Q4 2020, and up 6.14% sequentially from $11.2 million in Q4 2020.
Compugen (CGEN) Share-based Compensation (2018 - 2021) Analysis & Trends
Compugen (CGEN) has 4 years of Share-based Compensation data on file, last reported at $11.9 million in Q4 2021.
- For the quarter ending Q4 2021, Share-based Compensation rose 6.14% year-over-year to $11.9 million; the trailing twelve-month figure through Dec 2021 stood at $11.9 million (up 6.14% YoY), and the FY2025 full-year result was $1.9 million, changed N/A from the prior year.
- Share-based Compensation climbed to $11.9 million in Q4 2021, from $11.2 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $11.9 million in Q4 2021 to a low of $4.9 million in Q4 2019.
- A 4-year average of $8.3 million and a median of $8.2 million in 2018 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation decreased 5.59% in 2019 and jumped 127.91% in 2020, its largest moves.
- Tracing CGEN's Share-based Compensation over 4 years: stood at $5.2 million in 2018, then retreated by 5.59% to $4.9 million in 2019, then jumped by 127.91% to $11.2 million in 2020, then climbed by 6.14% to $11.9 million in 2021.
- Business Quant data shows CGEN's Share-based Compensation at $11.9 million in Q4 2021, $11.2 million in Q4 2020, and $4.9 million in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 11.93 Mn |
| Dec 31, 2021 | 11.93 Mn |
| Dec 31, 2020 | 11.24 Mn |
| Dec 31, 2020 | 11.24 Mn |
| Dec 31, 2019 | 4.93 Mn |
| Dec 31, 2019 | 4.93 Mn |
| Dec 31, 2018 | 5.22 Mn |
| Dec 31, 2018 | 5.22 Mn |